ClearikonFLEX™ making smarter wound care a reality.
ClearikonFLEX™ making smarter wound care a reality.
The hospital wound care market is a substantial and steadily growing segment, driven by the rising prevalence of chronic wounds, an aging population, and increasing rates of diabetes and obesity. In the United States, the hospital segment accounted for approximately 29.5% of the global chronic wound care market, which was valued at $18.6 billion in 2025, translating to an estimated $5.49 billion for hospital-based wound care. By 2035, this is projected to reach $7.88 billion, reflecting a CAGR of 3.7%.
The global home healthcare market for wound care is valued at $3.5 billion in 2025, projected to reach $4.8 billion by 2035 (CAGR 3.1%). In the US, chronic wounds affect approximately 6.5 million people annually, with home health agencies playing a critical role in managing these patients.
The global combat casualty care (combat dressing) market is valued at $5.77 billion in 2025, projected to reach $7.17 billion by 2035 (CAGR 2.2%). The US Department of Defense (DoD) is the primary buyer, with significant procurement budgets for trauma care R&D, battlefield wound care, and smart medical devices.
The global veterinary bandage (animal wound care) market is valued at $1.47 billion in 2025, projected to reach $2.10 billion by 2030 (CAGR 7.4%). The US market is estimated at $316.2 million in 2024, growing to $466 million by 2030 (CAGR 6.8%).
Market Advantage
*Non-Adherent (Non-Stick) Current Competitive Dressings include products like 3M Tegaderm, 3M™ Adaptic™, Mepitel™, Telfa™, and Dynarex™.
Nurses will be the primary users. Hospitals, clinics and home health organizations will acquire product from distributors, group purchasing organizations, and eCommerce channels.
Expand new product awareness via trade shows, speaking events, video promotions, social media, eCommerce and printed collateral.
Product sales activities will target corporate partners, medical product distributors, and eCommerce channels.
Products will be sold at a premium price via new CMS Reimbursement codes, and direct customer payment.
Initial forecast price will be $85/unit.